Press Releases from Profacgen (2 total)
Profacgen Enhanced Its Structure-based Virtual Screening (SBVS) Service Recently
Profacgen, a biotechnology company that provides custom protein services in the biological sciences, recently enhanced its structure-based virtual screening service for scientists in the field of drug discovery and lead optimization.
In structure-based virtual screening (SBVS), potential compounds are computationally docked into the 3D structure of the biological target using biophysical techniques including X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy, homology modeling, or molecular dynamics simulation. Then, the projected binding affinity…
Profacgen Provides Protein Ubiquitination Services to Accelerate Drug Developmen …
Profacgen, an experienced provider in biological research and drug discovery, provides various ubiquitin services to help customers accelerate research progress and obtain better results.
Ubiquitination is one of the most prevalent post-translational modifications (PTMs) in cells. Ubiquitin modification induces protein degradation, which affects the function, localization, and activity of proteins. Therefore, the study of protein ubiquitination plays an important role in cell biology and drug discovery.
With the comprehensive advanced platform, Profacgen…
Go To Page: 1
